Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism

Xu, 2004, Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth, Stem Cells, 22, 972, 10.1634/stemcells.22-6-972

Barberi, 2005, Derivation of multipotent mesenchymal precursors from human embryonic stem cells, PLoS Med, 2, 554, 10.1371/journal.pmed.0020161

Olivier, 2006, Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells, Stem Cells, 24, 1914, 10.1634/stemcells.2005-0648

Trivedi, 2008, Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells, Exp Hematol, 36, 350, 10.1016/j.exphem.2007.10.007

Lian, 2007, Derivation of clinically compliant MSCs from CD105 +, CD24− differentiated human ESCs, Stem Cells, 25, 425, 10.1634/stemcells.2006-0420

Baxter, 2004, Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion, Stem Cells, 22, 675, 10.1634/stemcells.22-5-675

Le Blanc, 2007, Immunomodulation by mesenchymal stem cells and clinical experience, J Intern Med, 262, 509, 10.1111/j.1365-2796.2007.01844.x

Prasad, 2011, Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study, Biol Blood Marrow Transplant, 17, 534, 10.1016/j.bbmt.2010.04.014

Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559

Corcione, 2006, Human mesenchymal stem cells modulate B-cell functions, Blood, 107, 367, 10.1182/blood-2005-07-2657

Batten, 2006, Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves, Tissue Eng, 12, 2263, 10.1089/ten.2006.12.2263

Klyushnenkova, 2005, T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression, J Biomed Sci, 12, 47, 10.1007/s11373-004-8183-7

Maccario, 2005, Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4 + T-cell subsets expressing a regulatory/suppressive phenotype, Haematologica, 90, 516

Plumas, 2005, Mesenchymal stem cells induce apoptosis of activated T cells, Leukemia, 19, 1597, 10.1038/sj.leu.2403871

Rasmusson, 2005, Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms, Exp Cell Res, 305, 33, 10.1016/j.yexcr.2004.12.013

Krampera, 2006, Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells, Stem Cells, 24, 386, 10.1634/stemcells.2005-0008

Meisel, 2004, Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation, Blood, 103, 4619, 10.1182/blood-2003-11-3909

Nasef, 2009, Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation, Int J Lab Hematol, 31, 9, 10.1111/j.1751-553X.2007.00997.x

Ren, 2009, Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression, Stem Cells, 27, 1954, 10.1002/stem.118

Selmani, 2008, Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 + CD25highFOXP3 + regulatory T cells, Stem Cells, 26, 212, 10.1634/stemcells.2007-0554

Le Blanc, 2003, HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells, Exp Hematol, 31, 890, 10.1016/S0301-472X(03)00110-3

Lee, 2002, Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division, Immunology, 107, 452, 10.1046/j.1365-2567.2002.01526.x

Munn, 1998, Prevention of allogeneic fetal rejection by tryptophan catabolism, Science, 281, 1191, 10.1126/science.281.5380.1191

Frumento, 2002, Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase, J Exp Med, 196, 459, 10.1084/jem.20020121

Zaher, 2011, 3-hydroxykynurenine suppresses CD4 + T cell proliferation, induces T regulatory cell development and prolongs corneal allograft survival, Invest Ophthalmol Vis Sci., 52, 2640, 10.1167/iovs.10-5793

Yen, 2009, Brief report. Human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes, Stem Cells, 27, 451, 10.1634/stemcells.2008-0390

Haniffa, 2007, Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells, J Immunol, 179, 1595, 10.4049/jimmunol.179.3.1595

Jones, 2007, The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells, J Immunol, 179, 2824, 10.4049/jimmunol.179.5.2824

Liu, 2007, Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages, Stem Cells, 25, 750, 10.1634/stemcells.2006-0394

Tan, 2005, Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy, Blood, 105, 3824, 10.1182/blood-2004-10-3880

Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905

Wada, 2011, Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells, Stem Cells Dev, 20, 647, 10.1089/scd.2010.0246

Muller, 2006, Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors, Nat Rev Cancer, 6, 613, 10.1038/nrc1929